Exploring Carcinoid Syndrome in Neuroendocrine Tumors: Insights from a Multidisciplinary Narrative Review
Cancers · 14.11.2024 · 16 (22) · 3831
DOI: 10.3390/cancers16223831 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 14.11.2024. Verfasst von Matteo Marasco und 9 weiteren Autor:innen. Beteiligte Einrichtung: Digestive Disease Unit, Sant' Andrea University Hospital, ENETS Center of Excellence, 00189 Rome, Italy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Carcinoid syndrome (CS) is a rare condition associated with neuroendocrine tumors (NETs), particularly those originating in the gastrointestinal tract, which secrete bioactive substances like serotonin. The management of CS requires a multidisciplinary approach due to its complex clinical manifestations, including flushing, diarrhea, bronchospasm, and carcinoid heart disease. Optimal care involves collaboration between several professional figures like oncologists, endocrinologists, gastroenterologists, surgeons, and dietitians. Currently, a wide range of treatments are available, focused on both symptom control and tumor burden reduction. Somatostatin analogs (SSAs) are the first-line therapy for symptom relief. Still, in patients with progressive disease or refractory CS, other options include targeted therapies, peptide receptor radionuclide therapy (PRRT), liver-directed therapies, and surgical resection, when feasible. Furthermore, management of complications related to prolonged serotonin release and malnutrition as a result of exocrine pancreatic insufficiency, post-surgical conditions, vitamin deficit, and chronic diarrhea often requires early detection to mitigate symptoms and improve the quality of life in these patients. The complexity of CS necessitates individualized care and continuous coordination among specialists to optimize outcomes and enhance patient well-being.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Digestive Disease Unit, Sant' Andrea University Hospital, ENETS Center of Excellence, 00189 Rome, Italy.
- PhD School in Translational Medicine and Oncology, Department of Medical and Surgical Sciences and Translational Medicine, Faculty of Medicine and Psychology, Sapienza University of Rome, 00185 Rome, Italy.
- Oncology Unit, Sant' Andrea University Hospital, ENETS Center of Excellence, 00189 Rome, Italy.
- Nuclear Medicine Unit, Sant' Andrea University Hospital, ENETS Center of Excellence, 00189 Rome, Italy.
- Radiology Unit, Sant' Andrea University Hospital, ENETS Center of Excellence, 00189 Rome, Italy.
- Department of Medical and Surgical Sciences and Translational Medicine, Sapienza University of Rome, 00185 Rome, Italy.
ORCID-Profile: Matteo Marasco, Giulia Arrivi, Damiano Caruso, Antongiulio Faggiano, Francesco Panzuto
Zitieren
APA
Marasco, M., Romano, E., Arrivi, G., Prosperi, D., Rinzivillo, M., Caruso, D., Mercantini, P., Rossi, M., Faggiano, A., & Panzuto, F. (2024). Exploring Carcinoid Syndrome in Neuroendocrine Tumors: Insights from a Multidisciplinary Narrative Review. Cancers, 16(22), 3831. https://doi.org/10.3390/cancers16223831
Vancouver
Marasco M, Romano E, Arrivi G, Prosperi D, Rinzivillo M, Caruso D, et al. Exploring Carcinoid Syndrome in Neuroendocrine Tumors: Insights from a Multidisciplinary Narrative Review. Cancers. 2024;16(22):3831. doi:10.3390/cancers16223831
BibTeX
@article{Marasco2024,
author = {Marasco, Matteo and Romano, Elena and Arrivi, Giulia and Prosperi, Daniela and Rinzivillo, Maria and Caruso, Damiano and Mercantini, Paolo and Rossi, Michele and Faggiano, Antongiulio and Panzuto, Francesco},
title = {Exploring Carcinoid Syndrome in Neuroendocrine Tumors: Insights from a Multidisciplinary Narrative Review},
journal = {Cancers},
year = {2024},
volume = {16},
number = {22},
pages = {3831},
doi = {10.3390/cancers16223831}
}
EUVIMED